Vitexin Induces Apoptosis in MCF-7 Breast Cancer Cells through the Regulation of Specific miRNAs Expression

被引:11
作者
Najafipour, Reza [1 ]
Momeni, Abdol Mabood [2 ]
Mirmazloomi, Yousef [3 ]
Moghbelinejad, Sahar [4 ]
机构
[1] Univ Social Welf & Rehabil Sci, Genet Res Ctr, Tehran, Iran
[2] Khatam Pathobiol & Genet Lab, Qazvin, Iran
[3] Qazvin Univ Med Sci, Sch Med, Shahid Bahonar Blvd, Qazvin, Iran
[4] Qazvin Univ Med Sci, Res Inst Prevent Noncommunicable Dis, Cellular & Mol Res Ctr, Shahid Bahonar Blvd, Qazvin, Iran
关键词
Vitexin; MicroRNA; breast cancer; apoptosis; PATHWAY; PROLIFERATION; ACTIVATION; MICRORNAS; INVASION; MICE;
D O I
10.22088/IJMCM.BUMS.11.3.197
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In this research, we investigated microRNAs (miRNAs) expression profile in MCF-7 breast cancer cell line which treated with 150 mu M vitexin. Profiling of miRNAs expression was performed using TaqMan MiRNA Array. Apoptosis was analyzed by flow cytometry and the expression of some genes involved in "anti-proliferative" signaling pathways were evaluated by western blotting and real time PCR methods. Twenty microRNAs were differentially expressed in vitexin treated cells compared to the control. Among them, let-7-b, c were up regulated while miRNA-17-5p was down regulated with highest score. Also, we detected the expression changes of mentioned miRNAs target genes as well as genes involved in caspase apoptosis pathways. Our results provide the first evidence that vitexin can effect miRNA expression in MCF-7 cells. Also based on our finding, vitexin can be an attractive miRNA mediated chemo preventive and therapeutic agent in breast cancer.
引用
收藏
页码:197 / +
页数:10
相关论文
共 30 条
[1]   The impact of molecular subtype on breast cancer recurrence in young women treated with contemporary adjuvant therapy [J].
Alabdulkareem, Hanan ;
Pinchinat, Tiffany ;
Khan, Sarah ;
Landers, Alyssa ;
Christos, Paul ;
Simmons, Rache ;
Moo, Tracy-Ann .
BREAST JOURNAL, 2018, 24 (02) :148-153
[2]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[3]  
Choi HJ, 2006, MOL CELLS, V22, P291
[4]  
Felekkis K, 2010, HIPPOKRATIA, V14, P236
[5]   Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis [J].
Feng, Yixiao ;
Spezia, Mia ;
Huang, Shifeng ;
Yuan, Chengfu ;
Zeng, Zongyue ;
Zhang, Linghuan ;
Ji, Xiaojuan ;
Liu, Wei ;
Huang, Bo ;
Luo, Wenping ;
Liu, Bo ;
Lei, Yan ;
Du, Scott ;
Vuppalapati, Akhila ;
Luu, Hue H. ;
Haydon, Rex C. ;
He, Tong-Chuan ;
Ren, Guosheng .
GENES & DISEASES, 2018, 5 (02) :77-106
[6]   Oncogenic MicroRNAs: Key Players in Malignant Transformation [J].
Frixa, Tania ;
Donzelli, Sara ;
Blandino, Giovanni .
CANCERS, 2015, 7 (04) :2466-2485
[7]   Potential toxicity of flavonoids and other dietary phenolics: Significance for their chemopreventive and anticancer properties [J].
Galati, G ;
O'Brien, PJ .
FREE RADICAL BIOLOGY AND MEDICINE, 2004, 37 (03) :287-303
[8]   The hallmarks of cancer [J].
Hanahan, D ;
Weinberg, RA .
CELL, 2000, 100 (01) :57-70
[9]   Vitexin suppresses autophagy to induce apoptosis in hepatocellular carcinoma via activation of the JNK signaling pathway [J].
He, Jin-Dan ;
Wang, Zhen ;
Li, Shi-Peng ;
Xu, Yan-Jie ;
Yu, Yao ;
Ding, Yi-Jie ;
Yu, Wen-Li ;
Zhang, Rong-Xin ;
Zhang, Hai-Ming ;
Du, Hong-Yin .
ONCOTARGET, 2016, 7 (51) :84520-84532
[10]   Micrornas: Small RNAs with a big role in gene regulation [J].
He, L ;
Hannon, GJ .
NATURE REVIEWS GENETICS, 2004, 5 (07) :522-531